Therapy Areas
Latest News
AstraZeneca reports positive Phase III results for BREZTRI in uncontrolled asthma
13 February 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) reported on Friday that full results from the Phase III KALOS and LOGOS trials, published in The Lancet Respiratory Medicine, show that AstraZeneca's BRE...
Hoth Therapeutics granted US patent for novel exon-skipping therapy targeting allergic diseases
13 February 2026 - US biopharmaceutical company Hoth Therapeutics Inc (NASDAQ:HOTH) announced on Thursday that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for 'Exon Skipping of FC-Epsilon-RI-Beta and MS...
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
13 February 2026 - Clinical-stage biotechnology company Centivax Inc announced on Thursday that the first participants have been dosed in the company's Phase 1A clinical trial evaluating Centi-Flu 01, a pan-influenza universal flu vaccine, in he...
DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval
13 February 2026 - Generic pharmaceutical company DifGen Pharmaceuticals announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for Fluorometholone Ophthalmic Suspension, 0.1%, a complex generic formulation...
Innovent reports first participant dosed in Phase 3 trial of IBI354 for first-line treatment of HER2-positive breast cancer
13 February 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Thursday that the first participant has been successfully dosed in the pivotal Phase 3 clinical study (HeriCare-Breast01) of IBI354.The trial is eva...
Devonian reports gene expression data showing Thykamine's molecular effects in MASH model
...
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
...